{"url":"https://lda.senate.gov/api/v1/filings/82acbf2f-8495-4a42-a60e-e3d7dd70a0d0/","filing_uuid":"82acbf2f-8495-4a42-a60e-e3d7dd70a0d0","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2022,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/82acbf2f-8495-4a42-a60e-e3d7dd70a0d0/print/","filing_document_content_type":"text/html","income":"75000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"DAVID J. SCHIAPPA","dt_posted":"2022-10-20T15:32:24-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 7th Street NW","registrant_address_2":"Suite 825","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":12675,"url":"https://lda.senate.gov/api/v1/registrants/12675/","house_registrant_id":31811,"name":"THE DUBERSTEIN GROUP INC.","description":"Consulting","address_1":"325 7th Street NW","address_2":"Suite 825","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID J. SCHIAPPA","contact_telephone":"+1 202-728-1100","dt_updated":"2026-07-24T11:16:57.603169-04:00"},"client":{"id":117713,"url":"https://lda.senate.gov/api/v1/clients/117713/","client_id":1002297,"name":"PHRMA INC.","general_description":"Represents leading research-based pharmaceutical and biotechnology companies in the US","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-02-25"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Drug pricing Outreach re: TRIPS waiver Issues related to the Food and Drug Amendments Act of 2022","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":14074,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59537,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"J","last_name":"SCHIAPPA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71388,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":"KATE","middle_name":"WINKLER","last_name":"KEATING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":79182,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"R","last_name":"HOWARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}